Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00235781 · ClinicalTrials.gov registry record · NA
Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00235781 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 90 participants.
The verdict
NCT00235781, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The aim of this trial is to compare the safety and efficacy of a single dose of Thymoglobulin, rabbit derived antithymocyte globulin (Thymoglobulin, SangStat, Fremont, CA) to our standard four dose, four day Thymoglobulin induction regimen from the time of transplantation through a six month follow-up period. The primary endpoint will be the incidence of acute rejection. Secondary endpoints will include serious adverse events, evaluation of renal function, patient and graft survival, incidence of infectious complications, incidence of post-transplantation lymphoproliferative disorder (PTLD), duration and extent of lymphocyte depletion and immunoassays for evidence of recipient immune response to the allograft as well as duration of hospital stay.
Interventions
- DRUG Thymoglobulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00235781
The ClinicalTrials.gov registry entry for NCT00235781 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thymoglobulin is the first listed.
NCT00235781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00235781 about?
NCT00235781 is a clinical study titled "Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients". The aim of this trial is to compare the safety and efficacy of a single dose of Thymoglobulin, rabbit derived antithymocyte globulin (Thymoglobulin, SangStat, Fremont, CA) to our standard four dose, four day Thymoglobulin induction regimen from the time of transplantation through a six month follow-...
What is the current status of trial NCT00235781?
This trial is currently terminated. It is a NA study. The enrollment target is 90 participants. The study started on 2006-01. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00235781?
The interventions under investigation include: Thymoglobulin (DRUG).
Who is sponsoring clinical trial NCT00235781?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.